Search A Light In The Darkness

Sunday 12 February 2023

Big Data, Transhumanism and Why the Singularity May Be Faked

 I recently interviewed investigative journalist Whitney Webb about her two-volume book series, “One Nation Under Blackmail.” She’s been on tour, promoting the books in dozens of interviews.

Here, we discuss some of her experiences since the release of her books, and delve deeper into the disturbing merger of the intelligence state, Silicon Valley and medicine, and how transhumanism — eugenics rebranded — is being rolled out under the guise of health care.

We also talk about censorship and other tactics used to mold public perception, and how artificial intelligence may be overhyped to give technocrats and eugenicists carte blanche to do whatever they want without having any accountability.

As a former contributor to Mint Print Press News, which provides a lot of great coverage on the encroaching surveillance state, Webb knows a thing or two about Orwellian systems of control. Much of her work there focused on the intersection of intelligence agencies and Silicon Valley.


“Even after I left and started to do my own thing, I maintained a lot of that focus,” she says. “I guess a theme of my work would be the structure of power and how it really works. If you’re looking at Silicon Valley today, it’s very clear that it’s essentially fused with the national security state …

One thing we’ve seen happen, specifically during the COVID era, is that Big Pharma is now getting in this mix. There’s a lot of merging happening between Big Pharma and Silicon Valley. You’re seeing this with a lot of joint ventures into the health care space of Silicon Valley companies. A lot of it’s through wearables and these efforts to normalize technology like CRISPR or nanotechnology injectables.

You’re seeing them all come together, and a lot of these joint ventures or companies in this particular space that’s spanning big pharma in Silicon Valley tend to have a lot of funding from groups like In-Q-Tel, which is the CIA’s venture capital arm.

I think we’re seeing, in the effort to push through this technocratic transhumanist system, a lot more overlap between the power structure of the national security state in Silicon Valley with Big Pharma. And that’s very, very bad. I don’t know how else to put that.

It’s awful. I think more people should be paying a lot more attention to that specifically … [There’s] an effort to frame transhumanism — which is really the new eugenics — as health care, and that’s what a lot of this is about.”

As we record this in late November 2022, we seem to be in a bit of a lull, in terms of tyrannical overreaches. It’s a bit like being in the eye of a hurricane. You know the storm will be upon you yet, again, it’s only a matter of time. The question is, what comes next?


“I think there’s a couple things to watch really closely in the next year,” Webb says. “One is how this World Health Organization Pandemic Treaty, which tries to [supersede] the Constitution, not just of the U.S. but pretty much every country that signs it.

That’s definitely something to pay close attention to, because if that does get passed, I think it’s likely we’ll see an effort to repeat a lot of what we saw during COVID 19 from these particular groups. And if it’s not signed, I think they’re going to wait …

They’re waiting to get that type of new authority so they don’t have to deal with so much dissent, whether it’s from nation states or from particular domestic populations that have had enough and are unlikely to believe all of this a second time.

I think they’re really counting on having that WHO super-national authority in order to go forward with the biosecurity agenda, in terms of a repeat of what we saw in recent years.

The other thing I think is really important is the central bank digital currency (CBDC) agenda. Almost every country in the world at this point — there are exceptions, but I think it’s a majority — have some sort of CBDC pilot program going on right now. In the U.S., they’ve even announced they’re doing pilots of [CBDCs] with commercial banks like JP Morgan and some of the big financial giants of Wall Street.

I would say that either 2023 or 2024 is likely to be the year of the CBDC. In countries where they’ve already launched a CBDC, or have a very advanced pilot program, it’s framed first as voluntary, and then of course, once enough people start using it, it becomes the only form of legal tender in use. At least that’s the end game for CBDCs in any particular country.”...<<<Read More>>>...